Sqz Biotechnologies Co Stock Current Ratio
| SQZDelisted Stock | USD 0.10 0.04 28.57% |
Sqz Biotechnologies Co fundamentals help investors to digest information that contributes to Sqz Biotechnologies' financial success or failures. It also enables traders to predict the movement of Sqz Stock. The fundamental analysis module provides a way to measure Sqz Biotechnologies' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Sqz Biotechnologies stock.
Sqz |
Sqz Biotechnologies Co Company Current Ratio Analysis
Sqz Biotechnologies' Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.
Current Sqz Biotechnologies Current Ratio | 3.87 X |
Most of Sqz Biotechnologies' fundamental indicators, such as Current Ratio, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Sqz Biotechnologies Co is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Typically, short-term creditors will prefer a high current ratio because it reduces their overall risk. However, investors may prefer a lower current ratio since they are more concerned about growing the business using assets of the company. Acceptable current ratios may vary from one sector to another, but the generally accepted benchmark is to have current assets at least as twice as current liabilities (i.e., Current Ration of 2 to 1).
CompetitionIn accordance with the recently published financial statements, Sqz Biotechnologies Co has a Current Ratio of 3.87 times. This is 32.99% higher than that of the Biotechnology sector and 44.71% lower than that of the Health Care industry. The current ratio for all United States stocks is 79.17% lower than that of the firm.
Sqz Current Ratio Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Sqz Biotechnologies' direct or indirect competition against its Current Ratio to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Sqz Biotechnologies could also be used in its relative valuation, which is a method of valuing Sqz Biotechnologies by comparing valuation metrics of similar companies.Sqz Biotechnologies is currently under evaluation in current ratio category among its peers.
Sqz Fundamentals
| Return On Equity | -1.05 | |||
| Return On Asset | -0.33 | |||
| Operating Margin | (3.92) % | |||
| Current Valuation | (6.5 M) | |||
| Shares Outstanding | 29.49 M | |||
| Shares Owned By Insiders | 3.12 % | |||
| Shares Owned By Institutions | 66.58 % | |||
| Number Of Shares Shorted | 811.15 K | |||
| Price To Book | 0.50 X | |||
| Price To Sales | 1.24 X | |||
| Revenue | 21.03 M | |||
| Gross Profit | (43.05 M) | |||
| EBITDA | (59.28 M) | |||
| Net Income | (79.46 M) | |||
| Cash And Equivalents | 63.71 M | |||
| Cash Per Share | 3.61 X | |||
| Total Debt | 27.47 M | |||
| Debt To Equity | 0.74 % | |||
| Current Ratio | 3.87 X | |||
| Book Value Per Share | 1.36 X | |||
| Cash Flow From Operations | (83.55 M) | |||
| Short Ratio | 27.26 X | |||
| Earnings Per Share | (2.16) X | |||
| Price To Earnings To Growth | (0.03) X | |||
| Target Price | 19.0 | |||
| Number Of Employees | 53 | |||
| Beta | 2.71 | |||
| Market Capitalization | 12.83 M | |||
| Total Asset | 99.9 M | |||
| Retained Earnings | (274.97 M) | |||
| Working Capital | 46.36 M | |||
| Z Score | -4.76 | |||
| Net Asset | 99.9 M |
About Sqz Biotechnologies Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Sqz Biotechnologies Co's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sqz Biotechnologies using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sqz Biotechnologies Co based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in producer price index. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Other Consideration for investing in Sqz Stock
If you are still planning to invest in Sqz Biotechnologies check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Sqz Biotechnologies' history and understand the potential risks before investing.
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |